Single IRB Review for Cooperative Research: Sponsor and Site Responsibilities
The 2018 implementation of the NIH single IRB (sIRB) mandate fundamentally changed how cooperative research is conducted across multiple sites. What was once a fragmented landscape of individual institutional reviews has evolved into a streamlined system designed to improve efficiency while maintaining robust participant protections. However, this shift has created new questions about who is responsible for what—and when.
Understanding the distinct responsibilities of sponsors and participating sites under single IRB review is critical for compliance, efficiency, and maintaining the ethical integrity of multi-site research.
What Is Single IRB Review?
Single IRB review means that one IRB provides ethical oversight for all sites participating in a cooperative research study conducted in the United States. Rather than each institution conducting its own independent review, participating sites rely on a single IRB of record to review and approve the protocol, informed consent documents, and ongoing study oversight.
This approach, mandated by the NIH for most federally funded multi-site studies and encouraged by FDA regulations, aims to:
- Reduce duplication of effort across institutions
- Accelerate study startup timelines
- Ensure consistency in participant protections
- Streamline the review of protocol modifications and safety reports
For more background on the differences between single and multiple IRB models, see our guide on single IRB vs multiple IRBs.
The Sponsor's Core Responsibilities
In cooperative research, the sponsor—whether a pharmaceutical company, academic institution, federal agency, or other entity—carries significant responsibilities for establishing and maintaining the single IRB framework.
Selecting and Engaging the IRB of Record
The sponsor must identify and contract with an appropriate IRB to serve as the single IRB of record. This selection should consider:
- Expertise: Does the IRB have experience with the study type, intervention, and participant population?
- Capacity: Can the IRB handle the volume and timeline requirements?
- Regulatory standing: Is the IRB properly registered and in good standing?
- Technology: Does the IRB provide systems for efficient communication with multiple sites?
Many sponsors engage commercial or central IRBs for multi-site studies because of their infrastructure and experience with cooperative research models. Learn more about choosing the right IRB in our complete guide to selecting an IRB for clinical trials.
Developing the Master Protocol and Documents
The sponsor is responsible for creating the master study protocol and associated documents that the single IRB will review, including:
- The complete research protocol with detailed procedures
- Informed consent templates (which may require site-specific modifications)
- Recruitment materials
- Investigator brochures or device manuals
- Data and safety monitoring plans
These documents must be comprehensive enough to address variations across sites while maintaining study consistency.
Facilitating Site Participation Agreements
The sponsor must establish clear agreements that define:
- How sites will rely on the single IRB's determinations
- Processes for local context review
- Reporting pathways for adverse events and protocol deviations
- Communication channels between sites and the IRB
These agreements ensure all parties understand their roles and responsibilities under the sIRB model.
Managing Ongoing IRB Communications
Throughout the study, sponsors typically serve as the central point of contact with the IRB of record for:
- Submitting protocol amendments
- Reporting serious adverse events and unanticipated problems
- Coordinating continuing review submissions
- Distributing IRB determinations and approvals to all sites
This centralized communication model prevents confusion and ensures consistent information flow.
Ensuring Site Compliance
The sponsor must monitor participating sites to ensure they:
- Conduct research according to the IRB-approved protocol
- Adhere to informed consent requirements
- Report required information through appropriate channels
- Maintain required documentation
This oversight responsibility doesn't diminish site obligations—it complements them.
Participating Site Responsibilities
While the single IRB conducts the primary ethical review, participating sites retain critical responsibilities that cannot be delegated.
Local Context Assessment
Each site must evaluate whether the research is appropriate for its local context, considering:
- Community standards: Are the research methods and recruitment approaches acceptable in the local community?
- Resource availability: Does the site have adequate facilities, equipment, and personnel?
- Regulatory compliance: Can the site meet all applicable local, state, and institutional requirements?
- Participant population: Is the research appropriate for the specific population the site will recruit?
This assessment ensures that the research fits within the institution's mission and capabilities, even when relying on an external IRB's review.
Institutional Authorization
Sites must formally authorize the research to proceed at their location. This institutional authorization process typically involves:
- Reviewing the sIRB-approved protocol and consent documents
- Confirming investigator qualifications and training
- Verifying adequate resources and facilities
- Assessing any conflicts of interest
- Approving site-specific informed consent modifications (if needed)
Institutional authorization is distinct from IRB approval—it's the institution's official permission for the research to occur under its auspices.
Investigator Qualification and Training
Sites must ensure that their local investigators and research staff are:
- Appropriately qualified and credentialed
- Trained in human subjects protections
- Familiar with the specific protocol requirements
- Prepared to fulfill their responsibilities
For comprehensive guidance on training requirements, see our article on training requirements for research investigators and study staff.
Local Consent Form Modifications
While the sIRB approves the master consent template, sites may need to make specific modifications for local requirements, such as:
- Adding institution-specific contact information
- Including required institutional language
- Addressing state-specific legal requirements
- Adjusting for local community considerations
These modifications must be reviewed and approved—either by the sIRB or through a streamlined institutional process—before implementation.
Ongoing Compliance and Reporting
Local investigators maintain responsibility for:
- Conducting research ethically: Following the approved protocol and protecting participants
- Obtaining informed consent: Ensuring the consent process is appropriate and documented
- Reporting adverse events: Communicating safety information through established channels
- Documenting deviations: Identifying and reporting protocol deviations
- Maintaining records: Keeping required research documentation
These responsibilities mirror those in any research study, regardless of the IRB model. For guidance on essential documentation practices, see our guide on research recordkeeping after IRB approval.
Participant Complaint Management
Sites must have processes to receive and address participant concerns and complaints, even when the sIRB is located elsewhere. Local investigators serve as the primary point of contact for participants and must respond appropriately to issues that arise. Learn more in our article on participant complaints in research.
The Interplay: Where Sponsor and Site Responsibilities Converge
Successful cooperative research under the sIRB model requires clear coordination between sponsors and sites in several key areas.
Communication Pathways
Establishing clear communication channels is essential:
- Site-to-sponsor-to-sIRB: Most communications flow through the sponsor to ensure consistency and prevent conflicting information
- Direct site-to-sIRB: Some urgent safety reports may warrant direct communication
- Sponsor-to-sites: Sponsors must promptly distribute sIRB determinations, approvals, and modifications
Defining these pathways in advance prevents confusion during the study.
Safety Reporting
Cooperative research requires coordinated safety monitoring:
- Sites report adverse events to sponsors according to protocol requirements
- Sponsors aggregate safety information across all sites
- Sponsors determine what requires reporting to the sIRB
- The sIRB reviews aggregated safety data and makes determinations
- Sponsors communicate sIRB determinations back to sites
This centralized approach provides a comprehensive safety overview while maintaining site awareness.
Protocol Modifications
When protocol changes are needed:
- The sponsor typically initiates amendments and submits them to the sIRB
- The sIRB reviews and approves (or requires modifications)
- The sponsor distributes approved amendments to all sites
- Sites implement changes according to approved timelines
- Sites may need institutional authorization for significant changes
This process ensures all sites operate under the same protocol version.
Common Challenges and Solutions
Despite its benefits, the sIRB model presents challenges that sponsors and sites must navigate.
Challenge: Institutional Policies That Conflict With sIRB Determinations
Sometimes institutional requirements exceed sIRB determinations (e.g., requiring additional consent language or procedures).
Solution: Early engagement between sponsors, sites, and the sIRB can identify potential conflicts. Institutions can request specific modifications through the sIRB or, if necessary, impose additional local requirements as a condition of institutional authorization.
Challenge: Delayed Institutional Authorization
Some sites struggle to complete institutional authorization efficiently, even after sIRB approval.
Solution: Sponsors can provide templates, checklists, and support to streamline institutional processes. Early engagement with sites—before sIRB submission—helps identify potential roadblocks.
Challenge: Unclear Reporting Responsibilities
Sites may be uncertain what information to report, when, and to whom.
Solution: The study protocol and site agreements should explicitly define reporting requirements, pathways, and timelines. Sponsor training sessions for site staff reinforce these expectations.
Challenge: Limited Site Understanding of Local Context Review
Sites may be unclear about what local context review entails when relying on an external sIRB.
Solution: Clear guidance documents explaining local context considerations help sites conduct meaningful assessments without duplicating the sIRB's ethical review. For more on navigating multi-site IRB responsibilities, see our article on reviewing IRB responsibilities in multi-site research.
Best Practices for Successful sIRB Cooperation
For Sponsors:
- Engage sites early: Include site input when developing protocols and selecting the sIRB
- Provide comprehensive documentation: Ensure the sIRB has all necessary information for thorough review
- Establish clear processes: Document communication pathways, reporting requirements, and timelines
- Support site needs: Offer training, templates, and responsive assistance
- Monitor efficiently: Implement systems to track approvals, amendments, and compliance across sites
For Sites:
- Understand your role: Recognize that reliance on an sIRB doesn't eliminate site responsibilities
- Complete local assessments thoroughly: Take local context review seriously
- Communicate proactively: Raise questions and concerns early
- Maintain documentation: Keep records of all institutional decisions and communications
- Train staff adequately: Ensure the research team understands sIRB processes and their responsibilities under this model
Regulatory Context and Compliance
The sIRB requirement stems from several regulatory sources:
- NIH Policy: Requires single IRB review for most multi-site studies (effective January 2018)
- Revised Common Rule: Permits and encourages cooperative research arrangements
- FDA Regulations: Allow and encourage use of central/independent IRBs for FDA-regulated research
Compliance requires understanding how these regulations apply to your specific study type and funding source. Both sponsors and sites share responsibility for ensuring regulatory compliance—the sponsor through proper sIRB engagement and oversight, sites through appropriate local authorization and conduct.
Looking Forward: The Evolution of Cooperative Research
The single IRB model continues to evolve as sponsors, sites, and IRBs gain experience with cooperative research arrangements. Technology platforms, standardized templates, and refined processes are making sIRB review increasingly efficient.
However, success ultimately depends on clear understanding of roles and responsibilities. Sponsors must provide leadership and infrastructure while respecting site autonomy in local decision-making. Sites must fulfill their obligations for local oversight while trusting the sIRB's ethical review. When both parties understand and execute their responsibilities effectively, the sIRB model delivers on its promise: efficient, consistent, high-quality ethical oversight that protects participants and advances science.
Conclusion
Single IRB review for cooperative research represents a significant advancement in how we conduct multi-site studies. By clarifying sponsor and site responsibilities—and understanding where these responsibilities intersect—research teams can navigate this model successfully.
Sponsors bear primary responsibility for selecting the sIRB, managing centralized communications, and ensuring consistency across sites. Sites retain essential obligations for local context assessment, institutional authorization, investigator oversight, and ethical conduct of research. Together, these complementary responsibilities create a framework for efficient, compliant, and ethical multi-site research.
Partner With Elemental IRB for Your Multi-Site Research
Navigating single IRB requirements for cooperative research requires an IRB partner with the expertise, technology, and responsiveness to support complex multi-site studies. Elemental IRB specializes in serving as the IRB of record for cooperative research, providing:
- Experienced review of multi-site protocols across diverse research types
- Responsive communication with sponsors and participating sites
- Technology platforms that streamline submissions and approvals
- Clear guidance on sponsor and site responsibilities
- Efficient processes that accelerate study startup
Whether you're a sponsor planning a multi-site trial or a site considering reliance on an external IRB, Elemental IRB offers the partnership you need for successful cooperative research. Contact us to learn how we can support your next study.